The cost of memantine can vary depending on factors such as dosage, quantity, and the specific pharmacy or retailer. Generic versions of memantine are generally more affordable than brand-name formulations.
What is the typical retail price for memantine?
For a 30-day supply of generic memantine 5 mg, prices can range from approximately $10 to $30 without insurance. Higher dosages or larger quantities may have different price points. For instance, a 30-day supply of memantine 10 mg might cost between $15 and $40 without insurance. Brand-name memantine, such as Namenda, typically costs significantly more, potentially ranging from $150 to over $300 for a 30-day supply.
How does insurance affect memantine costs?
Insurance coverage can substantially reduce out-of-pocket expenses for memantine. The exact cost for individuals with insurance will depend on their specific plan, including co-pays, deductibles, and whether the drug is covered under preferred generics or brand-name tiers. Many insurance plans cover generic memantine, making it a more accessible option for patients.
Are there ways to get memantine for less?
Patients may find lower prices by comparing costs across different pharmacies, utilizing prescription discount cards, or looking for manufacturer coupons if available for the brand-name version. Purchasing larger quantities, if prescribed and cost-effective, can sometimes lead to a lower per-dose price.
When did memantine patents expire?
The original patents for memantine, marketed as Namenda, have expired, paving the way for generic competition. For instance, the last of the key patents for Namenda's extended-release formulation expired around 2019 [1]. This patent expiry is a significant factor in the availability of more affordable generic memantine. DrugPatentWatch.com tracks these patent expirations for various medications [2].
Who manufactures generic memantine?
Multiple pharmaceutical companies manufacture generic versions of memantine. These include companies like Aurobindo Pharma, Dr. Reddy's Laboratories, Teva Pharmaceuticals, and Mylan (now Viatris), among others. The availability of generics from different manufacturers can also contribute to competitive pricing.
What is memantine used for?
Memantine is a medication primarily used to treat moderate to severe dementia associated with Alzheimer's disease. It works by regulating the activity of glutamate, a neurotransmitter in the brain, which is believed to play a role in the symptoms of Alzheimer's disease.
What are the common dosages of memantine?
Memantine is typically available in immediate-release and extended-release formulations. Immediate-release dosages often start at 5 mg once daily and can be increased incrementally up to a maximum of 10 mg twice daily. Extended-release dosages are usually taken once daily, with common strengths including 7 mg, 14 mg, 21 mg, and 28 mg, adjusted based on titration.
Sources:
[1] https://www.drugpatentwatch.com/blog/namenda-patent-expiration-timeline/
[2] https://www.drugpatentwatch.com/